CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options From Subclinical Atherosclerosis to Plaque Progression and Acute Coronary Events Effect of Evolocumab on Complex Coronary Disease Requiring Revascularization Can Biomarkers of Myocardial Injury Provide Complementary Information to Coronary Imaging? SR-B1 Drives Endothelial Cell LDL Transcytosis via DOCK4 to Promote Atherosclerosis Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS) Polygenic Scores to Assess Atherosclerotic Cardiovascular Disease Risk: Clinical Perspectives and Basic Implications

Original Research2021 Mar 25;12(1):1889.

JOURNAL:Nat Commun. Article Link

Membrane type 1 matrix metalloproteinase promotes LDL receptor shedding and accelerates the development of atherosclerosis

A Alabi, XD Xia, DW Zhang et al. Keywords: LDL receptor; soluble ectodomain; proteinase responsible for LDLR cleavage

Full Text PDF